Biomerieux Inc is recalling approximately 49,215 VITEK 2 - AST test kits because some recently manufactured cards have errors in the concentration of the antibiotic Ceftriaxone. These test kits are used in clinical laboratories to determine which antibiotics will be effective against a patient's infection. Due to this defect, the kits may incorrectly show that a bacterial infection is susceptible to treatment (meaning the drug would work) when it is actually resistant, potentially leading to ineffective medical treatment for patients. Consumers should contact their healthcare provider or the manufacturer regarding these diagnostic kits.
The concentration errors in the test cards can produce false 'susceptible' results for certain bacterial isolates. If a physician relies on these incorrect results, they may prescribe Ceftriaxone to treat an infection that is actually resistant to the drug, leading to treatment failure and serious health complications.
Manufacturer Notification and Technical Guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.